1. Home
  2. LCUT vs HURA Comparison

LCUT vs HURA Comparison

Compare LCUT & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifetime Brands Inc.

LCUT

Lifetime Brands Inc.

HOLD

Current Price

$7.34

Market Cap

131.2M

ML Signal

HOLD

Logo TuHURA Biosciences Inc.

HURA

TuHURA Biosciences Inc.

HOLD

Current Price

$2.30

Market Cap

144.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCUT
HURA
Founded
1945
2009
Country
United States
United States
Employees
N/A
22
Industry
Industrial Machinery/Components
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
131.2M
144.3M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
LCUT
HURA
Price
$7.34
$2.30
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$9.50
AVG Volume (30 Days)
111.9K
813.9K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
2.54%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$647,933,000.00
N/A
Revenue This Year
$3.74
N/A
Revenue Next Year
$1.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.90
$0.41
52 Week High
$8.20
$3.99

Technical Indicators

Market Signals
Indicator
LCUT
HURA
Relative Strength Index (RSI) 55.41 49.92
Support Level $3.45 $2.26
Resistance Level $7.83 $2.63
Average True Range (ATR) 0.81 0.21
MACD 0.03 -0.02
Stochastic Oscillator 79.74 43.48

Price Performance

Historical Comparison
LCUT
HURA

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S.-based company that designs, sources, and sells branded kitchenware, tableware, and other home solution products used in the home. The company's product portfolio comprises kitchen tools, cutlery, thermometers, cutting boards, spice racks, dinnerware, stemware, flatware, bath scales, thermal beverage ware, food storage, neoprene travel products, etc. These products are marketed under owned or licensed brands like Farberware, KitchenAid, Mikasa, Misto, Taylor, Sabatier, and Pfaltzgraff, among others. The company mainly sells its products directly to retailers and distributors, and a limited selection directly to consumers through its own websites. It has two reportable operating segments: U.S., which derives maximum revenue, and International.

About HURA TuHURA Biosciences Inc.

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

Share on Social Networks: